FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1978284904> ?p ?o ?g. }

• W1978284904 endingPage "889" @default.
• W1978284904 startingPage "885" @default.
• W1978284904 abstract "In Brief Study Design. A retrospective chart review of all patients who underwent posterior cervical fusion during a 1-year time period. Objective. To analyze the safety profile of recombinant human bone morphogenetic protein (rhBMP)-2 in posterior cervical fusion. Summary of Background Data. Use of rhBMP-2 in anterior cervical spine surgery has been associated with complications including postoperative edema, dysphagia, and hematoma formation. No literature exists regarding the safety of rhBMP-2 use for posterior cervical fusion. Methods. We reviewed all posterior cervical fusions performed during 1 year at our hospital following institutional review board permission. Results. A total of 83 patients underwent posterior cervical fusion. Sixty-seven (81%) did not receive rhBMP (control group), whereas 16 (19%) underwent fusion with rhBMP. The most common reason for the use of rhBMP was a failure of an anterior cervical fusion resulting in persistent neck pain, myelopathy, or radiculopathy. The average dose of rhBMP used was 1.3 mL per level. Immediate postoperative medical complications occurred in 5 (7%) in the control group and 2 (13%) in the rhBMP group. A new neurologic deficit after surgery was found in 3 (4%) in the control group and 1 (6%) in the rhBMP group. Wound infection requiring further surgery occurred in 8 (12%) in the control group, and in none in the rhBMP group. One (6%) patient in the rhBMP group had significant postoperative neck swelling, but improved with steroid treatment over 1 week, and without any compromise of vital neck structures. No postoperative hematomas were seen in either group. χ2 analysis revealed that no complication variable reached significance (P < 0.05) when the 2 groups were compared. Conclusion. rhBMP can safely be used in patients undergoing posterior cervical fusion, as it does not produce complications at the rate previously seen with its use in the anterior cervical spine. The use of recombinant bone morphogenetic protein in the setting of cervical fusion is controversial, with numerous reports of complications with its use in the anterior cervical spine. In this study, we showed that bone morphogenetic protein can be used in the setting of posterior cervical fusion to promote fusion." @default.
• W1978284904 created "2016-06-24" @default.
• W1978284904 creator A5017972156 @default.
• W1978284904 creator A5042480699 @default.
• W1978284904 creator A5080052337 @default.
• W1978284904 date "2009-04-01" @default.
• W1978284904 modified "2023-10-07" @default.
• W1978284904 title "Is It Safe to Use Recombinant Human Bone Morphogenetic Protein in Posterior Cervical Fusion?" @default.
• W1978284904 cites W154876906 @default.
• W1978284904 cites W155750289 @default.
• W1978284904 cites W1966639987 @default.
• W1978284904 cites W1968822620 @default.
• W1978284904 cites W1999829265 @default.
• W1978284904 cites W2039839585 @default.
• W1978284904 cites W2050457057 @default.
• W1978284904 cites W2057067590 @default.
• W1978284904 cites W2074433534 @default.
• W1978284904 cites W2140102422 @default.
• W1978284904 cites W2154128099 @default.
• W1978284904 cites W2156097368 @default.
• W1978284904 cites W2281132827 @default.
• W1978284904 cites W2329311838 @default.
• W1978284904 cites W3000473592 @default.
• W1978284904 cites W4239171241 @default.
• W1978284904 doi "https://doi.org/10.1097/brs.0b013e31819e334a" @default.
• W1978284904 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19531997" @default.
• W1978284904 hasPublicationYear "2009" @default.
• W1978284904 type Work @default.
• W1978284904 sameAs 1978284904 @default.
• W1978284904 citedByCount "31" @default.
• W1978284904 countsByYear W19782849042013 @default.
• W1978284904 countsByYear W19782849042014 @default.
• W1978284904 countsByYear W19782849042015 @default.
• W1978284904 countsByYear W19782849042016 @default.
• W1978284904 countsByYear W19782849042017 @default.
• W1978284904 countsByYear W19782849042021 @default.
• W1978284904 countsByYear W19782849042022 @default.
• W1978284904 crossrefType "journal-article" @default.
• W1978284904 hasAuthorship W1978284904A5017972156 @default.
• W1978284904 hasAuthorship W1978284904A5042480699 @default.
• W1978284904 hasAuthorship W1978284904A5080052337 @default.
• W1978284904 hasConcept C104317684 @default.
• W1978284904 hasConcept C118552586 @default.
• W1978284904 hasConcept C121608353 @default.
• W1978284904 hasConcept C126322002 @default.
• W1978284904 hasConcept C141071460 @default.
• W1978284904 hasConcept C142724271 @default.
• W1978284904 hasConcept C167135981 @default.
• W1978284904 hasConcept C185592680 @default.
• W1978284904 hasConcept C204787440 @default.
• W1978284904 hasConcept C2776531899 @default.
• W1978284904 hasConcept C2776944266 @default.
• W1978284904 hasConcept C2777479560 @default.
• W1978284904 hasConcept C2777604421 @default.
• W1978284904 hasConcept C2777740455 @default.
• W1978284904 hasConcept C2779662492 @default.
• W1978284904 hasConcept C2780375110 @default.
• W1978284904 hasConcept C2780775167 @default.
• W1978284904 hasConcept C2781038967 @default.
• W1978284904 hasConcept C31507581 @default.
• W1978284904 hasConcept C55493867 @default.
• W1978284904 hasConcept C71924100 @default.
• W1978284904 hasConceptScore W1978284904C104317684 @default.
• W1978284904 hasConceptScore W1978284904C118552586 @default.
• W1978284904 hasConceptScore W1978284904C121608353 @default.
• W1978284904 hasConceptScore W1978284904C126322002 @default.
• W1978284904 hasConceptScore W1978284904C141071460 @default.
• W1978284904 hasConceptScore W1978284904C142724271 @default.
• W1978284904 hasConceptScore W1978284904C167135981 @default.
• W1978284904 hasConceptScore W1978284904C185592680 @default.
• W1978284904 hasConceptScore W1978284904C204787440 @default.
• W1978284904 hasConceptScore W1978284904C2776531899 @default.
• W1978284904 hasConceptScore W1978284904C2776944266 @default.
• W1978284904 hasConceptScore W1978284904C2777479560 @default.
• W1978284904 hasConceptScore W1978284904C2777604421 @default.
• W1978284904 hasConceptScore W1978284904C2777740455 @default.
• W1978284904 hasConceptScore W1978284904C2779662492 @default.
• W1978284904 hasConceptScore W1978284904C2780375110 @default.
• W1978284904 hasConceptScore W1978284904C2780775167 @default.
• W1978284904 hasConceptScore W1978284904C2781038967 @default.
• W1978284904 hasConceptScore W1978284904C31507581 @default.
• W1978284904 hasConceptScore W1978284904C55493867 @default.
• W1978284904 hasConceptScore W1978284904C71924100 @default.
• W1978284904 hasIssue "9" @default.
• W1978284904 hasLocation W19782849041 @default.
• W1978284904 hasLocation W19782849042 @default.
• W1978284904 hasOpenAccess W1978284904 @default.
• W1978284904 hasPrimaryLocation W19782849041 @default.
• W1978284904 hasRelatedWork W1166051521 @default.
• W1978284904 hasRelatedWork W199761723 @default.
• W1978284904 hasRelatedWork W2070021170 @default.
• W1978284904 hasRelatedWork W2126810021 @default.
• W1978284904 hasRelatedWork W2149589955 @default.
• W1978284904 hasRelatedWork W2396640391 @default.
• W1978284904 hasRelatedWork W2405105294 @default.
• W1978284904 hasRelatedWork W2407740235 @default.
• W1978284904 hasRelatedWork W2797012994 @default.
• W1978284904 hasRelatedWork W3092538436 @default.

• next